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Abstract
Background: In guided bone regeneration (GBR) technique, many materials have been used for improving biological
effectiveness by adding on membranes. The new membrane which was constructed with chitin-fibroin-hydroxyapatite
(CNF/HAP) was compared with a collagen membrane (Bio-Gide®) by means of micro-computed tomography.
Methods: Fifty-four rats were used in this study. A critical-sized (8 mm) bony defect was created in the calvaria with a
trephine bur. The CNF/HAP membrane was prepared by thermally induced phase separation. In the experimental
group (n = 18), the CNF/HAP membrane was used to cover the bony defect, and in the control group (n = 18), a
resorbable collagen membrane (Bio-Gide®) was used. In the negative control group (n = 18), no membrane was used.
In each group, six animals were euthanized at 2, 4, and 8 weeks after surgery. The specimens were analyzed using
micro-CT.
Results: Bone volume (BV) and bone mineral density (BMD) of the new bone showed significant difference between
the negative control group and membrane groups (P < 0.05). However, between two membranes, the difference was
not significant.
Conclusions: The CNF/HAP membrane has significant effect on the new bone formation and has the potential to be
applied for guided bone regeneration.
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Background
Guided bone regeneration (GBR) is a valuable procedure
that uses a membrane to reconstruct bone defect in the
oral and maxillofacial area [1]. As a barrier of bone defect,
a membrane guards the region from invasion of in-growth
cells from fibrous connective tissue and promotes a favor-
able environment for cells derived from bone marrows [2].
For achieving a competent result, the GBR barrier mem-
brane requires certain properties such as bioactivity, bio-
compatibility, cell viability, and space-maintaining ability
during the bone healing process [1].
Since first reported by Boyne [3], who used a cellulose
acetate filter to regenerate bone in surgically created
mandibular defect, numerous materials for the membrane
have been introduced for enhancing the results of osteo-
genesis. A number of membranes are often divided based
on degradability. Non-degradable membranes such as ex-
panded polytetrafluoroethylene (ePTFE) are relatively thin
and can maintain sufficient intensity during the bone heal-
ing process; however, it must be removed by a secondary
operation, while degradable membranes do not require
additional procedures [4, 5]. Nowadays, the use of resorb-
able membranes is increased by clinicians and the most
widely used membrane is Bio-Gide® (Geistlich Pharma
AG, Wolhusen, Switzerland), which is made of porcine
collagen [6].
In our previous study, we reported the comparative
study of a chitosan-fibroin-hydroxyapatite (CFB-HAP)
membrane and collagen membrane for bone regener-
ation [7]. In that experiment, the CFB-HAP membrane
showed significant potential as a guided bone regener-
ation membrane. However, Shi et al. [8] reported that
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chitosan has a peculiar ability of granulation tissue for-
mation on dermo-epidermal lesions. And its stimulating
effect of inflammatory cell which has an inhibitory effect
of bacterial growth can lead to overexpressed inflamma-
tory response in vivo [9, 10]. To solve this problem, many
studies examined the application of chitin, acetylated
chitosan, which arouse mild inflammatory response. In
this study, a new membrane had been fabricated in which
chitosan was replaced by chitin.
The purpose of this study is to compare the new bone
formation and healing in rat skull defect using the new
chitin-fibroin-hydroxyapatite membrane and collagen
membrane (Bio-Gide®), which has been widely used at
dental offices as a barrier membrane of guided bone
regeneration, by means of computerized tomography
(micro-CT) analysis.
Methods
The material used in this study was a fabricated compos-
ite using chitosan, calcium hydroxyapatite, and fibroin.
Acetylation reaction was carried out, and the composite
was squeezed to obtain a membrane form [11].
Fabrication of a membrane
Prepared for the creation of new membrane materials
were the following: chitosan (Taehoon-bio Corp., Korea),
hydroxyapatite nanopowder (Sigma-Aldrich Corp.,
USA), and raw silk (produced by Bombyx mori silk-
worms, degummed and dissolved in a mixed solvent of
CaCl2, H2O, and ethanol; fibroin aqueous solution).
Chitosan was purified with diluted 2 wt% aqueous acetic
acid and 5 wt% sodium hydroxide solutions. The fibroin
aqueous solution was dialyzed in flowing water for
7 days. The hydroxyapatite nanoparticles were treated in
dry CO2 atmosphere for 48 h at 900 °C in electric furnace.
With this process, the carbonate group was substituted
with the hydroxyl group and/or the phosphate group of hy-
droxyapatite. The carbonate hydroxyapatite was thus syn-
thesized. The chitosan/carbonate hydroxyapatite composite
was prepared as follows. Carbonate hydroxyapatite was
uniformly dispersed in 2 wt% acetic acid solution; 3 wt%
chitosan was dissolved in carbonate hydroxyapatite-
dispersed solution at room temperature. The composites
were solidified in 10 wt% NaOH solution after casting on a
glass plate. The fabricated composites of film type were
washed with distilled water several times and were dried
slowly at room temperature. The chitosan/carbonate hy-
droxyapatite composites reacted with 1 M acetic anhydride
in methanol solution. The acetylation reaction was carried
out with stirring at 120 rpm at 25 °C for 24 h. After the
reaction, the composites were washed with methanol
solution to remove unreacted acetic anhydride and
by-products. The amino groups on the surface of the
composites were substituted with the acetamide groups by
acetylation.
Animal models and surgical procedures
Fifty-four Sprague-Dawley albinic male rats (15 weeks
old, Koatech, INC., Korea) weighing approximately 600
to 800 g were used as the animal experimental model in
this study. The venue used for this study was the Labora-
tory Animal Resource Center of Pusan National University
Yangsan Campus, under licensed by the Pusan National
University Institutional Animal Care and Use Committee
(PNU2011000241).
The animals were anesthetized with a mixture of
10 mg/kg of xylazine hydrochloride (Rumpun®, Bayer,
Korea) and 100 mg/kg of ketamine chloride (Ketalar®,
Yuhan Corporation, Korea). The dorsal area of rat cra-
nium was shaved before the surgery, while the surgical field
was prepared with an iodine solution. A midline incision
was performed on the skin following the muscle and peri-
osteum; the periosteum with muscles was reflected laterally.
About 8-mm diameter of bony defect was then created in
the center of the calvaria, with an 8-mm diameter trephine
bur (Hee Sung Cor. Seoul, Korea). This defect is considered
a critical-size bone defect because it does not heal spontan-
eously during the lifetime of the animal [12]. Each mem-
brane was trimmed off to be rectangular (10 mm×
10 mm), enough to cover the bony defects, and then
applied at the outer surface of the bony defect. The muscle
layers were closed with 4-0 Vicryl® sutures in a continuous
fashion, while the skin was closed with 3-0 Vicryl® sutures.
Gentamycin 5 mg/kg was injected for the prevention of
side effects after surgery. In the experimental group
(n = 18), chitin-hydroxyapatite-fibroin membrane was
used. In the control group (n = 18), an absorbable col-
lagen membrane (Bio-Gide®) was used. In the negative
control group (n = 18), a membrane was not used. In
each group, six animals were euthanized by CO2 at 2,
4, and 8 weeks post-surgery. After euthanasia, skulls were
harvested and fixed in 10 % formalin. They were taken to
the micro-CT.
Measurement of BV and BMD and 3D reconstruction
using micro-CT
Micro-CT scans were performed with a SKYSCAN 1172
high-resolution micro-CT (SkyScan N. V., Belgium).
Prior to scanning the specimens, a calibration scan was
performed using a synthetic bone, water, and air sample.
The exposure parameters were 70 kV and 140 μA. The
total scan time was 20 min. The reconstruction of
scanned images was done using the software (SkyScan
CT-analyzer) after calibrating the bone, water, and air
standard values. CT images were reconstructed using a
modified cone-beam algorithm [13] with an isotropic voxel
spacing of 0.027 × 0.027 × 0.027 mm3. The reconstructed
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three-dimensional (3D) image was then traced in three di-
mensions to the circumference of the original defect mar-
gins. This allowed the creation of a 3D reconstruction of
the defect, referred to as the region of interests (ROI). The
ROI of each specimen was analyzed for bone volume (BV)
and bone mineral density (BMD).
Statistical analysis
The bone defect was regarded as the statistical unit.
Data were expressed as mean ± standard deviation (SD).
One-way analysis of variance (ANOVA) was performed
to analyze BV and BMD. Each group was compared
using the Tukey post hoc test when a significant result
was presented. The level of significance was set to 0.05.
Results
Gross examination
In the negative control group, there was no inflammatory
change of tissue in all-sacrificial time. In the positive con-
trol (Bio-Gide®) group, after 2 weeks, the membrane was
resorbed a little. After 4 and 8 weeks, the membranes
were all resorbed and showed a good healing state. In the
experimental (chitin-fibroin-hydroxyapatite (CNF/HAP))
group, the membranes were not resorbed until 8 weeks
after surgery and mild inflammation was noted.
Micro-CT analysis
Bone volume
BV of the new bones that filled the bony defect showed
significant difference between the negative control group
and membrane groups, except the result of 4 weeks after
surgery. However, showing comparison between the two
membranes, the difference was not significant at the
time of all observations, although the bone volume level
of the Bio-Gide® group was higher than that of the CNF/
HAP group (Table 1, Fig. 1).
Bone mineral density
BMD measurements also showed significant yet different
results compared with the negative control group and
membrane groups. Similar to previous experimental
measurements, a tendency was seen wherein the result
of the membrane groups was higher than that of the
negative control group. However, according to statistical
tests, differences were observed in the period. In 2 weeks,
the results showed a similar pattern in the bone volume;
the postoperative 4 weeks showed significant differences
between the Bio-Gide® group and experimental group.
At 8 weeks after operation, no significant difference was
detected among all groups including the uncovered
group (Table 1, Fig. 2).
3D reconstruction images
Figure 3 shows the 3D reconstruction images where a
new bone was formed from the margin and the increase
in dependent time. There were more new bones in the
covered groups than in the void group.
Discussion
In this study, chitin as a form of acetylated chitosan was
used to resolve the problem of chitosan, inflammatory
reaction. Chitosan has been promoting the effect of
wound healing by stimulating inflammatory cell, and it
has an inhibitory effect of bacterial growth which can
lead to overexpressed inflammatory response in vivo
[9, 10]. The main biochemical effects of chitosan are
a fibroblast activation, cytokine production, and giant
cell migration. Chitosan has a peculiar ability to foster
adequate granulation tissue formation accompanied by
angiogenesis and regular deposition of thin collagen fibers,
a property that further enhances correct repair of dermo-
epidermal lesions [8]. To solve this problem, many studies
examined the application of chitin, which arouses mild
inflammatory response. Chitin is a polyheterosaccharide
comprised of glucosamine and N-acetyglucosamine units
Table 1 Measurements of the rat calvarial defect
Measurement Time Membrane P
valueVoid Bio-gide® CNF/HAP
BV 2 weeks 1.79 ± 0.52A 5.73 ± 1.74B 5.08 ± 1.10B 0.001*
4 weeks 3.16 ± 0.68A 6.49 ± 2.65B 5.63 ± 2.22AB 0.027*
8 weeks 4.78 ± 2.03A 8.59 ± 1.66B 7.43 ± 1.28B 0.007*
BMD 2 weeks 0.45 ± 0.04A 0.62 ± 0.04B 0.59 ± 0.10B 0.029*
4 weeks 0.58 ± 0.06A 0.79 ± 0.05B 0.67 ± 0.01C 0.019*
8 weeks 0.67 ± 0.08 0.79 ± 0.04 0.76 ± 0.19 0.213
Different uppercase letters indicate statistical difference within the same
line; *P < 0.05
BV= bone volume (mm3), BMD= bone mineral density (mg/ml), CNF/HAP=
chitin-hydroxyapatite-fibroin membrane
Fig. 1 Measurements of bone volume by micro-CT analysis (mm3).
CNF/HAP= chitin-fibroin-hydroxyapatite membrane
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linked by 1-4 glucosidic bonds; it has the properties of
biodegradability, biocompatibility, chemical inertness,
wound healing, and antibacterial and anti-inflammatory
activities [14]. Hence, chitin has recently gained interest
for its use in GBR membranes, as many studies present
positive results [15–18]. However, despite these attempts
to decrease or resolve the inflammatory reaction, some-
what sight inflammations were observed in the experi-
ment on animals of this study.
Despite good results from many studies which used
chitin as a membrane for guided bone regeneration
[15–18], problems with the exclusive use of chitin involve
its poor mechanical properties. Addition of hydroxyapatite
improves the mechanical properties of chitin [19].
However, this is a secondary objective; the main purpose
using hydroxyapatite in this study is to enhance the result
accompanying the ability of osteoconductivity. Hydroxy-
apatite, which is a natural inorganic component of the
bone and teeth, has already been used in orthopedics and
dentistry because of its osteoconductivity and osteophili-
city [20, 21], and it is used usually in particulate form as a
scaffold. Polymers combined with hydroxyapatite are cap-
able of promoting osteoblast adhesion, migration, differ-
entiation, and proliferation, especially useful for potential
applications in bone repair and regeneration [22, 23].
Hydroxyapatite particles have been incorporated into
chitosan matrixes to enhance the bioactivity of tissue-
engineering scaffolds for hard tissue regeneration [24].
The GBR barriers should have appropriate mechanical
properties such as sufficient strength and elasticity to
cover bone defects and block a down-growth of surround-
ing connective tissues in the implantation region. Silk
fibroin acts as an enzyme immobilization matrix with
good mechanical properties, as it has blood compatibility
and good dissolved oxygen permeability [25, 26]. Reports
have been made on silk fibroin/chitosan membranes with
good mechanical properties forming an interpenetrating
polymer network [27–29].
Bio-Gide® (Geistlich AG, Wolhusen, Switzerland),
which is composed of porcine type I and type III collagen
Fig. 2 Measurements of bone mineral density by micro-CT analysis
(mg/ml). CNF/HAP= chitin-fibroin-hydroxyapatite membrane
Fig. 3 The 3D reconstruction images of each groups at 2, 4, and 8 weeks. a 2-week negative control group. b 2-week control group. c 2-week experi-
mental group. d 4-week negative control group. e 4-week control group. f 4-week experimental group. g 8-week negative control group. h 8-week
control group. i 8-week experimental group. The new bone formations were examined in the two membrane groups more than in the negative con-
trol group. Bone formation was increased in a time-dependent manner and could be detected through the 3D images
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fibers, and has a bilayer structure composed of a “com-
pact” and “porous” layer, is a well-known and commonly
used collagen membrane for guided bone regeneration as
an absorbable membrane [30]. Membrane-derived colla-
gen fibers may trap some osteoinductive factors such as
bone morphogenetic proteins, transforming growth
factors, insulin-like growth factors, and fibroblast growth
factors that can be easily released from the bone matrix
when the artificial bone cavity was prepared. Even if colla-
gen itself has no ability to bind these osteoinductive fac-
tors, it can bind several extracellular matrixes that have
high affinity for these factors [31]. If so, several osteoin-
ductive factors may be possibly trapped by collagen fibers
of the membrane and make previously migrated cells
differentiate into an osteoblastic lineage. In addition, type
I collagen may directly play an important role in the
osteoblastic differentiation [32]. For the aforementioned
reasons, Bio-Gide® has been used by many clinicians as it
gained a reported high success rate when used for GBR.
The hypothesis in this experiment was as follows.
When the chitin-hydroxyapatite-fibroin composite is
applied as a membrane for guided bone regeneration,
the relatively fast degradation of chitin makes room for
the growth of new tissue and increases the opportunity
to assimilate hydroxyapatite with the host bone [33].
However, an unabsorbed membrane remained at 8 weeks
in the experimental group. This might have been due to
containing hydroxyapatite. Although hydroxyapatite is a
bioresorbable material, sufficient time for complete ab-
sorption is required. According to the report of Jansen
et al. [34], depending on the ratio of the hydroxyapatite,
at least 4 weeks is required for the identification of gross
absorption. At 8 weeks of the experimental group, the
time interval might be the cause of the remnant of
membranes. The time interval which was set in this
study was the result of considering clinical application,
where the time intervals of about 6 weeks or longer
between the operation and secondary surgery or implant-
ation [35] are generally applied for guided bone regener-
ation. It might be carefully expected that this problem
could be solved, if it is applied for a longer period.
Overall, the covered groups showed excellent results
compared with the uncovered group. However, based on
the comparative period, some difference was indicated
in the comparison of bone volume. These results can be
related to the experimental design. This study did not
use a filler to compare only the pure effect of the mem-
branes. Because of this, it might have varying degrees of
difference of the results. Schmid et al. also reported cer-
tain variations of bone healing when using bioresorbable
membranes without filler materials [36]. Although no
statistical differences showed in bone volume at 4 weeks
between the void group and experimental group, the
overall results do not deviate from the flow. A similar
result appears in BMD measurement. At 4 weeks after
surgery, there are higher values in the Bio-Gide group
than in the new membrane group in terms of BMD
measurement. However, 8 weeks after surgery, these differ-
ences disappeared, which shows similar results with the
control group. This might be due to the aforementioned
experimental design, if only limited to the result of 4 weeks.
However, it would be reasonable to infer the cause to con-
sider the characteristic of the BMD which is a measure-
ment of the bone maturity and could be affected by an
inflammatory response. If so, the results which showed the
not significant difference of BMD after 8 weeks, regardless
of the amount of the regenerated bone of all groups, could
be interpreted in the same point of view.
Conclusions
In this study, the CNF/HAP in the form of a membrane
was applied as the barrier membrane for guided bone re-
generation in a rat model. To assess the effectiveness,
micro-CT analysis and visualizations of the regenerated
osseous tissue with 3D reconstruction program were
used. In the positive control and experimental group,
the bone volume and bone mineral density, which are
indexes of bone regeneration, have higher values com-
pared with those in the negative control group. Similar
results were indicated comparing two membranes that
had been used in this report.
1) The CNF/HAP has a similar bone regeneration
ability compared with the collagen membrane.
2) The possibility of the CNF/HAP membrane is seen
as a barrier membrane in GBR.
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